DNMT1 and hepatocellular carcinoma: Future endeavours should aim to further analyse the DNA methylation mechanism in HCC, clarify the action mechanism of DNMT inhibitors, mitigate adverse effects, develop novel diagnostic and treatment modalities, pave the way for innovative clinical interventions and achieve real clinical translation.